Metraipolis › archive › dc_7e4fe800736b
[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide] — Europe PMC PMID:41640144
- Source
- Europe PMC (rus)
- Original
- https://europepmc.org/article/MED/41640144
- DOI
- 10.14341/probl13677
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T01:03:51.916Z
- SHA-256 of the archived text
5d98073b7d1d47d4c376ae4c6a2364f12334803d7abab099c8e4146bf753a203- Stable URL of this page
https://metraipolis.com/documento/dc_7e4fe800736b
How to cite
[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide] — Europe PMC PMID:41640144 — Europe PMC (rus), https://europepmc.org/article/MED/41640144 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e4fe800736b (Metraipolis archive dc_7e4fe800736b, sha256 5d98073b7d1d47d4c376ae4c6a2364f12334803d7abab099c8e4146bf753a203)
BibTeX
@misc{dc7e4fe800736b,
title = {[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide] — Europe PMC PMID:41640144},
howpublished = {Europe PMC (rus)},
url = {https://europepmc.org/article/MED/41640144},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e4fe800736b; sha256 5d98073b7d1d47d4c376ae4c6a2364f12334803d7abab099c8e4146bf753a203},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41640144. Agents can read the archived copy with the MCP tool read_document.